Because we showed that hepatic fibrosis/cirrhosis and cancer involves TM4SF5 (Fig. 2B, C), blockade of TM4SF5 function/activity may be a beneficial strategy for the treatment of TM4SF5-dependent liver diseases. The gene discussed is TM4SF5; the disease is Hepatic fibrosis.